Trial Profile
A Phase III, Multicenter, Open-Label Study To Evaluate The Efficacy, Safety, and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Jun 2014
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Immunodeficiency disorders
- Focus Therapeutic Use
- Sponsors Bio Products Laboratory
- 18 Jun 2014 New trial record